CEO Message

We welcome all of you.

Considerations of the characteristics of each patient, the treatment environment
and medication compliance according to the traits of the disease are regarded as
highly important factors, especially in pharmaceutical formulation development.
Medication compliance is the most essential part of developing formulations.
The treatment effect can be hugely impacted by medication complianceas
much as it is impacted by efficacy and safety.
Therefore, the invention of any new formulation to augment medication compliance
is not only inevitable but also a valuable procedure. Our company is accredited for
the originality of our platform technique, OD!FS®. We have been certified with
numerous patents in South Korea, Japan, the United States and Europe.
Along with commercialized products, we continue to implement our original
technology in other medications and operate a research pipeline to advance
domestic and international partnerships. We are dedicated to enhancing your convenience and leading your life in a new direction.
Jeong Tae Kim & Chin Wook Paeck, 
 
CEO of Corepharm Bio Co., Ltd.
검색 닫기